Potential of genetically engineered anti-ganglioside GD2 antibodies for cancer immunotherapy

Prog Brain Res. 1994:101:201-12.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / genetics*
  • Antibodies, Monoclonal / therapeutic use
  • Gangliosides / immunology*
  • Genetic Engineering*
  • Humans
  • Neoplasms / therapy*

Substances

  • Antibodies, Monoclonal
  • Gangliosides
  • ganglioside, GD2